A Los Angeles jury is hearing the case of Loren Kransky v. Johnson & Johnson, the manufacturer of the of the ASR XL hip implant device.
10,000 lawsuits have been filed against the J&J, claiming that the company was aware that the metal-on-metal hip implant devices was defective and that the company was negligent in not fully testing the device before marketing. Attorneys also claim that J&J was sluggish in pulling the devices from the U.S. market; DePuy continued to sell the hips in the American market for more than a year after they were banned from England, France and Australia. In those countries, because of national joint replacement databases, early data showed that the devices were failing at a rate of 12.5% within five years.
Kransky is a retired business guard who received his ASR XL hip implant in 2007 and he had to have the device removed and replaced in 2012. Kransky’s blood was tested in October of 2011 and it was found that he had seven times the normal level of the metal cobalt in his body.
Kransky’s attorney said, in his opening statement, “This hip, this medical implant, incorporated dangers to an extent beyond what any reasonable doctor would have anticipated or expected.”
It is believed that the metal-on-metal design of the hip can cause shedding of cobalt and chromium ions which can cause a condition called metallosis. Metallosis can be serious and has been linked to cancer, premature tissue death, inflammation and osteolysis or bone resorption.
Those implanted with the DePuy device are closely watching the outcome of Kransky’s case. J&J had offered a $200,000 case settlement to each of people who filed a lawsuit, according to some case watcher.
The first witness at Kransky’s trial was Magness Flet, a leader of a designed and troubleshooter for Johnson & Johnson who testified that DePuy identified early on problems with the ASR hip but rejected plans to redesign it even though the redesign would have potentially lowered the amount of cobalt and chromium shed by the device.
A second witness, Professor Dennis Bobyn, who is a specialist in Biomedical Engineering at McGill University, testified that the DePuy hip implant “has multiple design defects” which caused it’s high failure rate.
Washington Attorney Personally Represents Northwest Patients with their DePuy Claims
Herbert Farber, founder of The Farber Law Group, has been in the forefront of attorneys in the Pacific Northwest to educate himself on the Johnson & Johnson recall. As a recipient of two hip implants himself, Mr. Farber knows the first-hand the anguish of the victims. As an injury law attorney with 40 years trial experience, Mr. Farber provides legal representation for clients in the Pacific Northwest regarding their claims. He has partnered with a New York law firm as a co-counsel to provide access to leading witnesses in the field.
Contact Mr. Farber to schedule a personal and confidential case evaluation. Mr. Farber can explain to you the latest developments in the cases against DePuy. He will assist you in both obtaining high quality medical care and exams to document your condition.
Call us at 1-800-224-9087 to schedule your appointment.